March 9 (Reuters) - Algernon Pharmaceuticals Inc AGN.CD :
* ALGERNON SCALES UP MANUFACTURING OF NP-120 (IFENPRODIL) TO PREPARE FOR CORONAVIRUS AND ACUTE LUNG INJURY US CLINICAL TRIALS
* ALGERNON PHARMACEUTICALS - MADE DECISION TO BEGIN PRODUCTION OF NP-120 (IFENPRODIL) WITH A NEW INJECTABLE AND LONG ACTING ORAL RELEASE FORMULATION